10x Genomics (TXG) Assets Average (2019 - 2026)

10x Genomics has disclosed Assets Average across 8 years of filings, most recently posting $1.0 billion for Q2 2026.

• In Q2 2026, Assets Average rose 8.63% year-over-year to $1.0 billion; the TTM figure through Jun 2026 stood at $1.0 billion (up 8.63% YoY), while the FY2025 annual figure was $980.0 million, up 4.05% from the prior year.
• Assets Average came in at $1.0 billion for Q2 2026 at 10x Genomics, down from $1.0 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $1.0 billion in Q4 2025 to a low of $911.0 million in Q1 2025.
• Average Assets Average over 5 years is $980.5 million, with a median of $1.0 billion recorded in 2022.
• Year-over-year, Assets Average decreased 7.58% in 2024 and increased 12.9% in 2026.
• Over 5 years, Assets Average stood at $1.0 billion in 2022, then dropped by 5.51% to $956.8 million in 2023, then slipped by 2.99% to $928.2 million in 2024, then advanced by 11.44% to $1.0 billion in 2025, then slipped by 1.11% to $1.0 billion in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $1.0 billion in Q2 2026, $1.0 billion in Q1 2026, and $1.0 billion in Q4 2025.